Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$858M |
| 2 |
Costco
COST
|
+$557M |
| 3 |
UnitedHealth
UNH
|
+$551M |
| 4 |
Atlassian
TEAM
|
+$489M |
| 5 |
Northrop Grumman
NOC
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$579M |
| 2 |
TSMC
TSM
|
+$433M |
| 3 |
Airbnb
ABNB
|
+$426M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$341M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.22% |
| 2 | Consumer Discretionary | 23.3% |
| 3 | Healthcare | 16.47% |
| 4 | Financials | 9.42% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
National Vision
EYE
$1.85B
| $15.1M | 0.02% |
463,083
-14,486
| -3% | -$471K |
|
352
Burlington
BURL
$23.2B
| $15.1M | 0.02% |
134,911
-25,597
| -16% | -$3.73M |
|
353
Rush Enterprises Class A
RUSHA
$6.36B
| $15.1M | 0.02% |
515,838
-847,437
| -62% | -$27.3M |
|
354
Wintrust Financial
WTFC
$10.9B
| $15.1M | 0.02% |
184,739
-196,842
| -52% | -$16.7M |
|
355
Neurocrine Biosciences
NBIX
$16.4B
| $15M | 0.01% |
141,330
+2,214
| +2% | +$225K |
|
|
MMP
356
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $14.9M | 0.01% |
314,085
-63,099
| -17% | -$3.17M |
|
357
ON Semiconductor
ON
$18.3B
| $14.7M | 0.01% |
236,323
-4,240
| -2% | -$273K |
|
358
BCE
BCE
$20.6B
| $14.5M | 0.01% |
347,231
+4,642
| +1% | +$226K |
|
359
Keurig Dr Pepper
KDP
$41.8B
| $14.4M | 0.01% |
403,096
+3,759
| +0.9% | +$142K |
|
360
Integra LifeSciences
IART
$1.38B
| $14.4M | 0.01% |
340,365
+64,963
| +24% | +$3.33M |
|
|
RCM
361
DELISTED
R1 RCM Inc. Common Stock
RCM
| $14.1M | 0.01% |
760,380
+23,963
| +3% | +$546K |
|
362
Caterpillar
CAT
$401B
| $14M | 0.01% |
85,471
+34,980
| +69% | +$6.39M |
|
|
FFWM
363
DELISTED
First Foundation Inc
FFWM
| $14M | 0.01% |
769,811
-329,518
| -30% | -$6.54M |
|
364
Service Corp International
SCI
$11.6B
| $13.9M | 0.01% |
240,098
+2,313
| +1% | +$152K |
|
365
BioLife Solutions
BLFS
$1.65B
| $13.7M | 0.01% |
603,427
+147,324
| +32% | +$3.15M |
|
366
Chewy
CHWY
$9.84B
| $13.6M | 0.01% |
444,021
+24,780
| +6% | +$983K |
|
367
Canadian National Railway
CNI
$77.1B
| $13.6M | 0.01% |
126,031
+179
| +0.1% | +$21.3K |
|
368
Kinetik
KNTK
$3.56B
| $13.5M | 0.01% |
415,083
+142,274
| +52% | +$5.25M |
|
|
BRKL
369
DELISTED
Brookline Bancorp
BRKL
| $13.5M | 0.01% |
1,160,597
-618,837
| -35% | -$8.19M |
|
|
FOCS
370
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $13.2M | 0.01% |
419,697
-220,599
| -34% | -$8.42M |
|
371
Dow Inc
DOW
$21.4B
| $13.2M | 0.01% |
299,380
-794
| -0.3% | -$40.3K |
|
372
Sweetgreen
SG
$679M
| $12.7M | 0.01% |
687,033
+250,832
| +58% | +$4.28M |
|
373
Freeport-McMoran
FCX
$97.1B
| $12.7M | 0.01% |
464,289
-3,610
| -0.8% | -$106K |
|
374
AvalonBay Communities
AVB
$27.1B
| $12.4M | 0.01% |
67,203
-36,224
| -35% | -$7.31M |
|
375
iShares Russell 1000 Growth ETF
IWF
$127B
| $12M | 0.01% |
227,528
-588,496
| -72% | -$34.6M |
|
Similar funds
Jennison Associates's Q3 2022 Portfolio in Review
As of Q3 2022, Jennison Associates held 689 positions worth $101B, up 0.37% from $100B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates's Q3 2022 filing shows 75 new, 294 increased, 218 reduced and 90 closed positions. Its largest new stake was T-Mobile US: 1,657,443 shares worth $222M. The largest sale was Nike, an estimated $579M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2022 buy was T-Mobile US: 1,657,443 shares worth $222M.
- Jennison Associates added most to Vertex Pharmaceuticals in Q3 2022, an estimated $858M increase.
- Jennison Associates's biggest Q3 2022 reduction was Nike, cutting an estimated $579M.
- Jennison Associates fully exited Snap in Q3 2022, selling an estimated $197M.
- Jennison Associates's ten largest holdings make up 40% of its $101B portfolio in Q3 2022.
- Jennison Associates opened 75 new positions and closed 90 in Q3 2022.
- Jennison Associates's portfolio value rose 0.37% quarter-over-quarter to $101B.
Based on Jennison Associates's 13F filing for Q3 2022, filed 1 Nov 2022.